G2 Investment Partners Initiates a New Position in Xometry

G2 Investment Partners initiated a new stake in Xometry (NASDAQ:XMTR) of 221,679 shares valued at $13.2M, representing 3.1% of the fund's AUM (fund AUM $420.7M at year-end). Xometry reported TTM revenue of $686.6M and a TTM net loss of $61.8M; Q4 revenue rose 30% y/y to $192M while GAAP Q4 loss narrowed to $8.6M from $9.9M. Shares have fallen 34.8% YTD (through Mar 17) but are up 50.9% over the last year; the filing signals institutional conviction but the company remains unprofitable under GAAP, warranting cautious investor assessment.

Analysis

Xometry’s economics are a classic marketplace lever: gross take-rate and supplier utilization drive margins far faster than top-line growth alone. If the company can convert even a few points of incremental take-rate via automation (instant quoting, yield tools, recurring supply agreements) the operating leverage is non-linear because most delivery cost sits with supplier partners. Conversely, a fragmenting supplier network or a step-up in supplier pricing power would compress gross margins quickly — platform firms can lose pricing control without stickier contractual frameworks.

Second-order winners include software vendors that embed into shop-floor workflows (CAM, MES, inspection/QA) and logistics providers that can monetize faster fulfillment; traditional job shops and low-mix high-volume EMS providers are the most exposed. An M&A pathway is plausible: incumbents buying marketplace capability would both validate the model and reprice competitive dynamics, accelerating consolidation in the addressable market.

Key risks are timing and cyclicality — durable GAAP profitability requires sustained margin expansion and retention across business cycles, so a macro-induced pullback in industrial capex or a supplier overcapacity shock could erase expected upside within quarters. From a positioning standpoint, the recent accumulation by an active manager signals conviction but not necessarily a catalyst; liquidity profile and event cadence (quarterly results, guidance cadence, product launches) should determine trade sizing and hedges.

Key Decisions for Investors

• Long XMTR via a defined-risk 9–12 month call‑spread (buy nearer‑term ITM call, sell a higher strike) sized to 1–3% of risk budget — asymmetric payoff if the company posts margin inflection; hedge with a 25–35% trailing stop on the spread premium to protect against cyclical hits.
• Relative pair: go long XMTR equity vs short CLS (or a comparable EMS/contract manufacturer) at 2:1 notional for 3–6 months to isolate marketplace take‑rate improvement from cyclical manufacturing weakness; target 30–50% relative outperformance, cut if XMTR customer cohort retention falls quarter‑over‑quarter.
• Event trade: small pre-earnings position (1% risk) in XMTR with protective puts sized to limit downside to that allocation; hold through the next two quarters—if revenue acceleration + margin guidance beats, add to position and convert puts to collars to lock gains.
• Hedge idea for existing long exposure: buy 3–6 month puts or build a collar to protect against a macroled capex pullback; cost can be subsidized by selling out‑of‑the‑money calls if willing to cap upside in near term.